Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study-Reference-Cited by-同舟云学术

Low prevalence of lipodystrophy in HIV-infected Senegalese children on long-term antiretroviral treatment: the ANRS 12279 MAGGSEN Pediatric Cohort Study

Published:2018-08-06 Issue:1 Volume:18 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Cames Cecile^ORCID, ,Pascal Lea,Ba Aissatou,Mbodj Hélène,Ouattara Baly,Diallo Ndeye-Fatou,Msellati Philippe,Mbaye Ngagne,Sy Signate Haby,Blanche Stephane,Diack Aminata

Funder

Agence Nationale de Recherche sur le SIDA et les hépatites virales

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-018-3282-7.pdf

Reference48 articles.

1. Duran S, et al. Failure to maintain long-term adherence to highly active antiretroviral therapy: the role of lipodystrophy. AIDS. 2001;15(18):2441–4.

2. Beregszaszi M, et al. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV-infected children. J Acquir Immune Defic Syndr. 2005;40(2):161–8.

3. Alam N, et al. Body fat abnormality in HIV-infected children and adolescents living in Europe: prevalence and risk factors. J Acquir Immune Defic Syndr. 2012;59(3):314–24.